Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets

Technology Criteria for the Manufacturing of Rebamipide Film-coated Tablets

Mostrar outras versões (1)

Introduction. The current growth of the pharmaceutical market and stiff competition require from drug manufacturers make a more detailed and thorough fine-tuning of existing production lines. Direct compression technology is a modern and cost-effective technology for solid dosage form drug manufactu...

ver descrição completa

Detalhes bibliográficos
Principais autores:	G. V. Trusov, B. V. Brovchenko, Z. M. Kozlova, I. I. Krasnyuk
Formato:	Artigo
Idioma:	Russian
Publicado em:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2023-12-01
coleção:	Разработка и регистрация лекарственных средств
Assuntos:	rebamipide direct compression dry granulation film-coated tablets
Acesso em linha:	https://www.pharmjournal.ru/jour/article/view/1663

Registros relacionados

Technology criteria for the manufacturing of Rebamipide film-coated tablets
por: G. V. Trusov, et al.
Publicado em: (2024-09-01)

Comparison of 2% Rebamipide and 0.1% Sodium Hyaluronate in the Treatment of Dry Eye
por: Ashok K Sharma, et al.
Publicado em: (2021-06-01)

Copolymerized Polymers Based on Cyclodextrins and Cationic Groups Enhance Therapeutic Effect of Rebamipide in the N-Acetylcysteine-Treated Dry Eye Model
por: Otake H, et al.
Publicado em: (2024-09-01)

Development of Amlodipine Mini-tablets as a Polypill-component for the Personalized Therapy of Arterial Hypertension
por: K. M. Tserkovnaya, et al.
Publicado em: (2023-12-01)

Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods
por: Kashiwagura Yasuharu, et al.
Publicado em: (2023-03-01)

Development of Celecoxib Granules for Manufacturing of Prolonged Release Celecoxib Capsules and Tablets
por: A. Alkhodri, et al.
Publicado em: (2022-02-01)

Rebamipide: thirty years of experience. A review
por: Natalia V. Bakulina, et al.
Publicado em: (2024-12-01)

Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets
por: Vlachou Marilena, et al.
Publicado em: (2020-03-01)

Recurrent aphthosic stomatitis: rebamipide – a new direction in treatment and prevention
por: Dmitry I. Trukhan, et al.
Publicado em: (2024-01-01)

Rational Function-Based Approach for Integrating Tableting Reduced-Order Models with Upstream Unit Operations: Dry Granulation Case Study
por: Sunidhi Bachawala, et al.
Publicado em: (2024-08-01)

Problems of Applying Film Coatings During Scale-up Technology
por: A. V. Strelkova, et al.
Publicado em: (2022-11-01)

REBAMIPIDE: EFFECTIVE DRUG PREVENTION OF NSAID ENTEROPATHY IS POSSIBLE
por: E. V. Moroz, et al.
Publicado em: (2016-12-01)

STUDIES OF THE DEVELOPMENT OF ORO-DISPERSIBLE TABLETS WITH AZITHROMYCIN
por: T. A. Pankrusheva, et al.
Publicado em: (2019-01-01)

PHARMACEUTICAL DEVELOPMENT: REVIEW OF EQUIPMENT FOR LABORATORY DEVELOPMENT AND PILOT BATCHES PRODUCTION OF SOLID DOSAGE FORMS
por: N. B. Diomina
Publicado em: (2019-01-01)

The possibility of using gastroenteroprotector rebamipide to improve the antithrombotic therapy safety
por: Natalya M. Vorobyeva, et al.
Publicado em: (2023-06-01)

Formulation and evaluation of fast disintegrating tablet of glimepiride
por: Arooj Khalid, et al.
Publicado em: (2018-07-01)

A study of compressibility and compactibility of directly compressible tableting materials containing tramadol hydrochloride
por: Mužíková Jitka, et al.
Publicado em: (2016-09-01)

Prediction of the composition of prolonged release tablets based on 4,4'-(propandiamido) sodium dibenzoate using the SeDeM method
por: Ju. M. Kotsur, et al.
Publicado em: (2021-12-01)

The effect of recompression and concentration of polyvinylpyrrolidone (PVP) K-30 on the quality of paracetamol tablets
por: Desak Made Rachel Angelina, et al.
Publicado em: (2024-07-01)

Controlled release kinetics of furosemide from chitosan matrix tablets with hydroxypropyl methylcellulose phthalate coated
por: Samran, et al.
Publicado em: (2024-07-01)

DEVELOPMENT OF NITROFURAN DERIVATIVE: COMPOSITION AND TECHNOLOGY OF EFFERVESCENT TABLETS WITH SOLID DISPERSIONS
por: A. O. Elagina, et al.
Publicado em: (2022-03-01)

Formulation, Standardization, and Characterization of a Novel Herbal Medicine Tablet Containing Rosehip Extract
por: Zahra Ayati, et al.
Publicado em: (2024-09-01)

Rebamipide Prevents the Hemoglobin Drop Related to Mucosal-Damaging Agents at a Level Comparable to Proton Pump Inhibitors
por: Ji Eun Kim, et al.
Publicado em: (2024-11-01)

Comparative evaluation of the use of dry binders in a physical mixture or as a coprocessed dry binder in matrix tablets with extended drug release
por: Mužíková Jitka, et al.
Publicado em: (2018-09-01)

Using Chia Powder as a Binder to Obtain Chewable Tablets Containing Quinoa for Dietary Fiber Supplementation
por: Rosana Pereira da Silva, et al.
Publicado em: (2024-04-01)

Rebamipide during chronic gastritis: <i>H. pylori</i> eradication therapy and restoration of gastric mucosa barrier function
por: Т. L. Lapina, et al.
Publicado em: (2024-01-01)

USE OF DISSOLUTION TEST FOR EVALUATION OF PHARMACEUTICAL EQUIVALENCE OF ATORVASTATIN GENERICS
por: O. V. Druzhininskaya, et al.
Publicado em: (2019-01-01)

Compressibility of tableting materials and properties of tablets with glyceryl behenate
por: Mužíková Jitka, et al.
Publicado em: (2015-03-01)

Pharmaceutical Equivalence of Film-Coated and Chewable Tablets: A Comparative Dissolution Study Using Pulverized Chewable Tablets
por: Suck-Yong Park, et al.
Publicado em: (2024-11-01)

Development of Dihydroquercetin-based Oral tablets and Evalution of the General Toxic Effect
por: S. A. Abdulrazzak, et al.
Publicado em: (2022-05-01)

New Prospects of Cytoprotection in the Treatment and Prevention of Gastric and Intestinal Diseases (Resolution of an Expert Council and Literature Review)
por: A. I. Martynov, et al.
Publicado em: (2020-05-01)

Komputer tablet /
por: Nurul 'Ula Noor 'Aaisa
Publicado em: (2014)

DEVELOPMENT OF PERORAL HYPOLIPIDEMIC FORMULATION BASED ON SULFATED ARABINOGALACTAN IN THE FORM OF POTASSIUM SALT
por: Ya. A. Kostyro, et al.
Publicado em: (2021-12-01)

Coating and drying defects : troubleshooting operating problems /
por: 282756 Gutoff, Edgar B., et al.
Publicado em: (2006)

Tablets (first revision)
por: 982 SIRIM

Design and evaluation of cost-effective oro-dispersible tablets of venlafaxine hydrochloride by effervescent method
por: Sunita Mahale, et al.
Publicado em: (2024-06-01)

A review on the role of co-processed excipients in tablet formulations
por: Ankita S. Burande, et al.
Publicado em: (2024-12-01)

Tablet /
por: 410665 Saringat Baie
Publicado em: (1984)

Misleading score-lines on tablets: facilitated intake or fractional dosing?
por: I Arnet
Publicado em: (2010-02-01)

Development of Enteric-coated Tablets of Sodium 4,4'-(propnadiamido)dibenzoate
por: Ju. M. Kotsur, et al.
Publicado em: (2022-05-01)